PMEF
CLOV icon

Point72 Middle East FZE’s Clover Health Investments CLOV Stock Holding History

Point72 Middle East FZE’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-376,751
Closed -$338K – 1503
2023
Q2 		$338K Buy
+376,751
New +$334K 0.01% 893
2023
Q1 		– Sell
-23,308
Closed -$21.7K – 1722
2022
Q4 		$21.7K Buy
+23,308
New +$31.1K ﹤0.01% 1623

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Point72 Middle East FZE's CLOV Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Clover Health Investments (CLOV) in Q3 2023, closing a stake of 376,751 shares — an estimated $338K sold.

Point72 Middle East FZE first reported a position in CLOV in Q4 2022 and held it in 2 quarters. The position peaked at $338K in Q2 2023. 143 funds tracked by Wall St. Rank hold CLOV as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Clover Health Investments position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 376,751 Clover Health Investments shares in Q3 2023, an estimated $338K.
  • Point72 Middle East FZE first reported a position in Clover Health Investments in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Clover Health Investments position peaked at $338K in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.